These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31571365)

  • 1. The "Psychosocial Aspects in Hereditary Cancer" questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German- and Spanish-language versions.
    Brédart A; Anota A; Dick J; Cano A; De Pauw A; Kop JL; Aaronson NK; Bleiker EM; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13173. PubMed ID: 31571365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
    Brédart A; Kop JL; Dick J; Cano A; De Pauw A; Anota A; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
    BMJ Open; 2019 Sep; 9(9):e029926. PubMed ID: 31551380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
    Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
    Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics.
    Eijzenga W; Bleiker EM; Hahn DE; Kluijt I; Sidharta GN; Gundy C; Aaronson NK
    Psychooncology; 2014 Aug; 23(8):862-9. PubMed ID: 24443031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Centered Care in Breast Cancer Genetic Clinics.
    Brédart A; Anota A; Dick J; Kuboth V; Lareyre O; De Pauw A; Cano A; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S; Kop JL
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29439543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
    Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
    Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and detection of psychosocial problems in cancer genetic counseling.
    Eijzenga W; Bleiker EM; Hahn DE; Van der Kolk LE; Sidharta GN; Aaronson NK
    Fam Cancer; 2015 Dec; 14(4):629-36. PubMed ID: 25968807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study.
    Brédart A; Kop JL; Tüchler A; De Pauw A; Cano A; Dick J; Rhiem K; Devilee P; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S
    Eur J Hum Genet; 2022 Sep; 30(9):1067-1075. PubMed ID: 35399119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
    Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial.
    Eijzenga W; Aaronson NK; Kluijt I; Sidharta GN; Hahn DE; Ausems MG; Bleiker EM
    BMC Cancer; 2014 Jan; 14():26. PubMed ID: 24428912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study.
    Brédart A; De Pauw A; Tüchler A; Lakeman IMM; Anota A; Rhiem K; Schmutzler R; van Asperen CJ; Devilee P; Stoppa-Lyonnet D; Kop JL; Dolbeault S
    Clin Genet; 2022 Jul; 102(1):30-39. PubMed ID: 35508697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
    Voorwinden JS; Jaspers JP
    J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling.
    Albada A; van Dulmen S; Lindhout D; Bensing JM; Ausems MG
    Fam Cancer; 2012 Mar; 11(1):85-95. PubMed ID: 21901499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cultural scale adaptation and validation of the Spanish version of the BRCA Self-Concept Scale in women carriers at high risk for hereditary breast and ovarian cancer].
    Castejón V; Rovira T; Sumalla EC; Darder E; Iglesias S; Ochoa C; Blanco I
    Med Clin (Barc); 2016 Feb; 146(4):148-54. PubMed ID: 26654557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial.
    Albada A; van Dulmen S; Bensing JM; Ausems MG
    Breast Cancer Res; 2012 Mar; 14(2):R37. PubMed ID: 22394647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review.
    Meiser B; Halliday JL
    Soc Sci Med; 2002 May; 54(10):1463-70. PubMed ID: 12061481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
    Katapodi MC; Munro ML; Pierce PF; Williams RA
    Nurs Res; 2011; 60(6):368-77. PubMed ID: 22048556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.